Inhaled Corticosteroids: Hazardous Effects on Voice-An Update

Journal of Voice

Volumn 21, Issue 1, 2007, Pages 101-111

  Gallivan, Gregory J ^a,b,c   Gallivan, K Holly ^d,e   Gallivan, Helen K ^f  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Mercy Medical Center   (United States)

^c Wing Memorial Hospital   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Winchester Hospital   (United States)

^f NONE

Author keywords

Amplitude magnitude; Fluticasone; Glottic closure; Glottic plane; Hoarseness dysphonia; Inhalation powder; Inhaled corticosteroids; Mucosal quality; Mucosal waves; Phase closure; Pressurized metered dose inhaler; Strobovideolaryngoscopy; Supraglottic hyperactivity; Symmetry periodicity; Videolaryngoscopy

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID DERIVATIVE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANDIDIASIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; COUGHING; DIPLOPHONIA; DRY THROAT; DYSPHAGIA; DYSPHONIA; FATIGUE; FEMALE; GLOTTIS; GLOTTIS DISEASE; HEMOPTYSIS; HOARSENESS; HUMAN; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; LARYNX CANDIDIASIS; LARYNX DISORDER; LARYNX MUCOSA; LARYNX SPASM; MALE; METERED DOSE INHALER; MUCOSAL DISEASE; ODYNOPHONIA; PARESIS; PRESBYPHONIA; SORE THROAT; STRIDOR; STROBOVIDEOLARYNGOSCOPY; TREATMENT DURATION; VOCAL CORD PARALYSIS; VOICE FATIGUE; WHEEZING;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANDROSTADIENES; FEMALE; GLOTTIS; HAZARDOUS SUBSTANCES; HOARSENESS; HUMANS; LARYNGITIS; LARYNGOSCOPY; MALE; METERED DOSE INHALERS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VOICE;

EID: 33845907948     PISSN: 08921997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvoice.2005.09.003     Document Type: Article

References (33)

1. Hanania N.A., Chapman K.R., and Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 98 (1995) 196-208
2. Lavy J.A., Wood G., Rubin J.S., and Harries M. Dysphonia associated with inhaled steroids. J Voice 14 (2000) 581-588
3. Roland N.J., Bhalla R.K., and Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 126 (2004) 212-219
4. Schleimer R.P. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 141 (1990) S59-S69
5. Taylor I.K., and Shaw R.J. The mechanism of action of corticosteroids in asthma. Respir Med 87 (1993) 261-277
6. Barnes P.J. Effect of corticosteroids on airway hyper-responsiveness. Am Rev Resp Dis 141 (1990) S70-S76
7. Barnes P.J. Anti-inflammatory therapy for asthma. Annu Rev Med 44 (1993) 229-242
8. Barnes P.J., Pedersen S., and Busse W.W. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 157 (1998) S1-S53
9. Dorland I, Newman WA, eds. Dorland's Illustrated Medical Dictionary. 28th ed. Philadelphia, PA: W.B. Saunders; 1994:517, 771.
10. Dubus J.C., Marguet C., Deshildre A., Mely L., Le Roux P., Brouard J., et al. Local side effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age and device. Allergy 56 (2001) 944-948
11. Dong J.C., Shen Z.Y., and Wang W.J. The investigation on 100 bronchial asthma and asthmatic bronchitis cases treated with high dose beclomethasone dipropionate aerosol. Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih 16 (1993) 33-35
12. Kriz R.J., Chmelik R., and Do Pico G. A one-year trial of triamcinolone acetonide aerosol in severe steroid-dependent asthma. Chest 72 (1977) 36-44
13. Williamson I.J., Matusiewicz S.P., Brown P.H., Greening A.P., and Crompton G.K. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 8 (1995) 590-592
14. Babu S., and Samuel P. The effect of inhaled steroids on the upper respiratory tract. J Laryngol Otol 102 (1988) 592-594
15. Williams A.J., Baghat M.S., Stableforth D.E., Cayton R.M., Shenoi P.M., and Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 38 (1983) 813-821
16. Toogood J.H., Jennings B., Baskerville J., Anderson J., and Johannson S.A. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis 65 (1984) 35-44
17. Shaw N.J., and Edmunds A.T. Inhaled beclomethosaone and oral candidiasis. Arch Dis Child 61 (1986) 788-790
18. Williams M.H., Kane C., and Shim C.S. Treatment of asthma with triamcinolone acetonide delivered by aerosol. Am Rev Respir Dis 109 (1974) 538-543
19. Lee L., Chamberlain L.G., Loudon R.G., and Stemple J.C. Speech segment durations produced by healthy and asthmatic subjects. J Speech Hear Disord 53 (1988) 186-193
20. Balter M.S., Adams S.G., and Chapman K.R. Inhaled beclomethasone dipropionate improves acoustic measures of voice in patients with asthma. Chest 120 (2001) 1829-1834
21. Watkin K.L., and Ewanowski S.J. The effects of triamcinolone acetonide on the voice. J Speech Hear Res 22 (1979) 446-455
22. Watkin K.L., and Ewanowski S.J. Effects of aerosol corticosteroids on the voice: triamcinolone acetonide and beclomethasone dipropionate. J Speech Hear Res 28 (1985) 301-304
23. Clarke P.M., Durham S.R., Perry A., and McKay I.S. Objective measurement of voice change caused by inhaled steroids. Voice 1 (1992) 63-66
24. Toogood J.H., Jennings B., Greenway R.W., and Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 102 (1980) 592-594
25. Bonet-Agusti M., and Casan-Clara P. Disfonia producida por corticoides en inhalacion: verdad o mito?. Arch-Bronconeumol 31 (1995) 415-417
26. Selroos O., Backman R., Forsen K.O., Lofroos A.B., Niemisto M., Pietinalho A., et al. Local side effects during 4-year treatment with inhaled corticosteroids- a comparison between pressurized metered-dose inhalers and Turbohaler. Allergy 49 (1994) 888-890
27. Davis K.C., and Small R.E. Budesonide inhalation powder: a review of its pharmacologic properties and role in the treatment of asthma. Pharmacotherapy 18 (1998) 720-728
28. Fabbri L., Burge P.S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., et al. Comparison of fluticasone proprionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 48 (1993) 817-823
29. Ayres J.G., Bateman E.D., Lundback B., and Harris T.A. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate 2 mg daily, or budesonide 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Resp J 8 (1995) 579-586
30. Pauwells R.A., Hargreave F.E., Camus P., Bukoski M., and Stahl E. A 1-year comparison of Turbuhaler versus pressurized metered-dose inhaler in asthmatic patients. Chest 110 (1996) 53-57
31. Clark D.J., and Lipworth B.J. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 52 (1997) 55-58
32. Harding S.M. The human pharmacology of fluticasone propionate. Respir Med 84 suppl A (1990) 25-29
33. Del Gaudio J.M. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Orolaryngol Head Neck Surg 128 (2002) 677-681